MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Sun Pharmaceutical Industries
Sun Pharmaceutical Industries
BSE: 524715|NSE: SUNPHARMA|ISIN: INE044A01036|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 31, 17:00
567.50
-13.75 (-2.37%)
VOLUME 104,739
LIVE
NSE
May 31, 17:00
566.95
-10.45 (-1.81%)
VOLUME 1,777,234
Earnings News on Sun Pharmaceutical Industries
Select Year: 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000-2004
Margins may be hit on one-off items in EBITDA: Sun Pharma 

5.04 pm | 30 May 2012 |  Source: CNBC-TV18

Uday Baldota, VP- investor relations, Sun Pharma tells CNBC-TV18 that apart from the drug Taro’s stellar contribution, other business segments also ...

Sun Pharma Q4 net sales up 60% at Rs 2330 cr 

11.17 am | 30 May 2012 |  Source: Moneycontrol.com

Drug maker Sun Pharma posted a spectacular 85% jump in March quarter net profit at Rs 820 crore, driven by strong sales of its Israeli unit Taro. ...

Sun Pharma expects 18-20% FY13 sales growth 

11.00 am | 30 May 2012 |  Source: Moneycontrol.com

Sun Pharmaceutical expects 18-20% sales growth in the current fiscal year that started in April, Managing Director Dilip Shanghvi said in an earnings ...

Sun Pharma Q4 cons PAT up 85% at Rs 820cr 

5.41 pm | 29 May 2012 |  Source: Moneycontrol.com

Sun Pharmaceutical Industries has announced its fourth quarter results. The company's Q4 consolidated net profit was up85% at Rs 820 crore versus Rs ...

Taro Q4 net income jumps 84% to USD 47.3 mn 

9.17 am | 25 May 2012 |  Source: Moneycontrol.com

Taro, a subsidiary of Sun Pharma, showed good growth in January-March quarter of 2012 on year-on-year basis, but there was dip in margins sequentially...

Sun Pharma Dec '11 sales at Rs 1,011.85 crore 

1.05 pm | 15 Feb 2012 |  Source: Moneycontrol.com

Sun Pharmaceutical Industries has reported a sales turnover of Rs 1,011.85 crore and a net profit of Rs 365.23 crore for the quarter ended Dec '11...

Sun Pharma Q3 net nearly doubles 

4.12 pm | 13 Feb 2012 |  Source: Reuters

Sun Pharmaceutical Industries, India's top drugmaker by market capitalisation, reported a better-than-expected 91% rise in December quarter net profit...

Sun Pharma Q3 cons PAT up 91% at Rs 668 cr 

3.34 pm | 13 Feb 2012 |  Source: Moneycontrol.com

Sun Pharma has announced its third quarter results. The company's Q3 consolidated net profit was up 91% at Rs 668 crore versus Rs 350 crore, year-on-y...

Sun Pharma Q3 PAT seen up 65% at Rs 576 cr 

10.36 am | 11 Feb 2012 |  Source: CNBC-TV18

Sun Pharmaceutical Industries, country's largest drugmaker by market cap, is set to announce its results for the quarter ended December FY12 on Monday...

Pharma Q3: New launches, generic drug demand to aid growth 

1.37 pm | 14 Jan 2012 |  Source: Moneycontrol.com

Pharmaceutical companies are expected to report healthy 15-25% year-on-year revenue growth in the third quarter, helped by new launches especially in ...

Pharmaceutical results preview for Q3FY12: Emkay 

6.34 pm | 10 Jan 2012 |  Source: Moneycontrol.com

Emkay Global Financial Services has come with its December quarterly earning estimates for pharmaceutical sector. According to the research firm the s...

1
Quick Links for Sun Pharmaceutical Industries
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.